IMR Press / EJGO / Volume 40 / Issue 3 / DOI: 10.12892/ejgo4620.2019
Open Access Original Research
P53 overexpression predicts unfavorable prognosis of low risk endometrial carcinoma
Show Less
1 West China Second Hospital of Sichuan University, Chendu, Sichuan, China
2 School of Medicine, Heath Science Center, Shenzhen University, Chendu, Sichuan, China
Eur. J. Gynaecol. Oncol. 2019 , 40(3), 463–467;
Published: 10 June 2019

Aim: Mutations of PTEN, p53 are the most frequent molecular defects in endometrial carcinomas (EC). Aim of this study was to investigate their prognostic significance in EC, especially for low risk EC. Materials and Methods: This retrospective study included 99 patients with diagnosed endometrial adenocarcinoma. Paraffin embedded specimens were studied immunohistochemically for detection of PTEN, p53 proteins. Correlation of p53 overexpression and loss expression of PTEN with several well-established prognostic parameters and survival rate were evaluated. Result: Overexpression of p53 was an independent prognostic factor for EC. Stratified analysis showed that p53 overexpression was a significant prognostic factor for low-grade (p < 0. 0001), early -stage (p < 0.0001), EC (< 0.0001), and non-nodal metastasis ones, but not for high-grade (p = 0.080), type II EC (p = 0.056), advanced EC (p = 0.632) or nodal metastasis ones (p = 0. 660). The present study failed to demonstrate that loss expression of PTEN was correlated with survival rate of EC. Conclusion: p53 overexpression was an independent prognostic factor of EC, especially for low-grade, early-stage, EC and nonnodal metastasis ones. Loss expression of PTEN was not correlated with survival rate of EC.

Endometrial carcinoma
Figure 1.
Back to top